SA-49, a new novel aloperine derivative, induced MITF-dependent lysosomal degradation of PD-L1 and suppressed Lewis tumor xenograft growth by activating immune microenvironment in C57BL/6 mice [30]. Here, CD274 is linked to neoplasm.